English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

ALEXANDRA DADARLAT1, DANA POP1,2*, ANCA DANIELA FARCAS1,3, DUMITRU ZDRENGHEA1,2, GYORGY BODIZS2, RALUCA TOMOAIA1, DIANA GURZU1, SILVANA SUSCA-HOJDA1, FLORINA FRINGU1, ANCA DANA BUZOIANU4 1 Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Victor Babes Str., 400012, Cluj Napoca, Romania 2 Clinical Rehabilitation Hospital, 46-50 Viilor Str., 400347, Cluj-Napoca, Romania 3 Emergency Clinical County Hospital, Cardiology Department, 3-5 Clinicilor Str, 400006, Cluj Napoca, Romania 4 Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania, Dept. of Pharmacology, Toxicology and Clinical Pharmacology

revista de chimie

CAN THE PRESENCE OF ATRIAL FIBRILLATION INFLUENCE THE LEVELS OF HEART FAILURE - SPECIFIC BIOMARKERS IN OVERWEIGHT AND OBESE PATIENTS WITH HEART FAILURE?